# Pirfenidone ameliorates lipopolysaccharide-induced pulmonary inflammation and fibrosis by blocking NLRP3 inflammasome activation

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/pirfenidone-ameliorates-lipopolysaccharide-induced-pulmonary-inflammation-and/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Yi Li,Haitao Li,Shuai Liu,Pinhua Pan,Xiaoli Su,Hongyi Tan,Dongdong Wu,Lemeng Zhang,Chao Song,Minhui Dai,Qian Li,Zhi Mao,Yuan Long,Yongbin Hu,Chengping Hu |
| Citations | 159 |
| DOI | 10.1016/j.molimm.2018.05.003 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2803657718 |
| PMID | 29783158 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Minhui Dai](https://scholariq.org/researchers/minhui-dai/)

## Paper primary topic

- [Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis](https://scholariq.org/topics/interstitial-lung-diseases-and-idiopathic-pulmonary-fibrosis/)

## Paper topics

- [Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis](https://scholariq.org/topics/interstitial-lung-diseases-and-idiopathic-pulmonary-fibrosis/)
- [Inflammasome and immune disorders](https://scholariq.org/topics/inflammasome-and-immune-disorders/)
- [Chronic Obstructive Pulmonary Disease (COPD) Research](https://scholariq.org/topics/chronic-obstructive-pulmonary-disease-copd-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.